The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier
Open accessAbstract
The treatment of central nervous system (CNS) disease has long been difficult due to the ineffectiveness of drug delivery across the blood-brain barrier (BBB). This review summarizes important concepts of the BBB in normal versus pathophysiology and how this physical, enzymatic, and efflux barrier provides necessary protection to the CNS during drug delivery, and consequently treatment challenging. Small molecules account for the vast majority of available CNS drugs primarily due to their ability to penetrate the phospholipid membrane of the BBB by passive or carrier-mediated mechanisms. Physiochemical and biological factors relevant for designing small molecules with optimal capabilities for BBB permeability are discussed, as well as the most promising classes of transporters suitable for small-molecule drug delivery. Clinically translatable imaging methodologies for detecting and quantifying drug uptake and targeting in the brain are discussed as a means of further understanding and refining delivery parameters for both drugs and imaging probes in preclinical and clinical domains. This information can be used as a guide to design drugs with preserved drug action and better delivery profiles for improved treatment outcomes over existing therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Medicinal chemical properties of successful central nervous system drugs
Pajouhesh, H., & Lenz, G. R. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.541 · Cited by 1,535
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Clark, C. M. (2011) · JAMA · doi:10.1001/jama.2010.2008 · Cited by 1,117
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Seelig, A., & Seelig, J. (1974) · Biochemistry · doi:10.1021/bi00720a024 · Cited by 977
Furuse, M., Itoh, M., Hirase, T., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.1617 · Cited by 962
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke · doi:10.1161/01.str.29.10.2189 · Cited by 861
PET versus SPECT: strengths, limitations and challenges
Rahmim, A., & Zaidi, H. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282f3a515 · Cited by 834
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
Neurological Disorders. Public Health Challenges
Vardi, G., & Merrick, J. (2007) · Journal of Policy and Practice in Intellectual Disabilities · doi:10.1111/j.1741-1130.2007.00122.x · Cited by 759
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679
Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660
Kratz (2004) · doi:10.1056/nejmcpc049016 · Cited by 593
The biology of brain metastases—translation to new therapies
Eichler, A. F., Chung, E., Kodack, D. P., Loeffler, J. S., Fukumura, D., & Jain, R. K. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.58 · Cited by 567
Predicting plasma protein binding of drugs: a new approach
Kratochwil, N. A., Huber, W., Müller, F., Kansy, M., & Gerber, P. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01074-2 · Cited by 553
Alzheimer's disease – do tauists and baptists finally shake hands?
Mudher, A., & Lovestone, S. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02031-2 · Cited by 514
The importance of neuritic plaques and tangles to the development and evolution of AD
Tiraboschi, P., Hansen, L. A., Thal, L. J., & Corey-Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000129697.01779.0a · Cited by 477
Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids
Oldendorf, W. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.6.1450 · Cited by 463
Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier
Smith, Q. R., Momma, S., Aoyagi, M., & Rapoport, S. I. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb01039.x · Cited by 454
Drug delivery to the central nervous system: a review.
Misra, A. R., Ganesh, S. D., Shahiwala, A., & Shah, S. P. (2003) · PubMed · Cited by 441
Mental health and development: targeting people with mental health conditions as a vulnerable group.
Funk, M. (2010) · Human Development Resource Network (HDRNet) · Cited by 423
Liu, H.-L., Hua, M.-Y., Yang, H.-W., Huang, C.-Y., Chu, P.-C., Wu, J.-S., Tseng, I.-C., Wang, J.-J., Yen, T.-C., Chen, P.-Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003388107 · Cited by 395
Deane, R., Wu, Z., & Zlokovic, B. V. (2004) · Stroke · doi:10.1161/01.str.0000143452.85382.d1 · Cited by 392
The movement of molecules across lipid membranes: A molecular theory
Träuble, H. (1971) · The Journal of Membrane Biology · doi:10.1007/bf02431971 · Cited by 391
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371
Drug delivery to the central nervous system: A review
Tamargo, R. J., & Brem, H. (1992) · Neurosurgery Quarterly · Cited by 369
Blood-Brain Barrier: Penetration of Morphine, Codeine, Heroin, and Methadone after Carotid Injection
Oldendorf, W. H., Hyman, S., Braun, L., & Oldendorf, S. Z. (1972) · Science · doi:10.1126/science.178.4064.984 · Cited by 362
Time-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Roux, F., Durieu‐Trautmann, O., Chaverot, N., Claire, M., Mailly, P., Bourre, J. ‐., Strosberg, A. D., & Couraud, P. ‐. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041590114 · Cited by 316
Kinetic analysis of blood-brain barrier transport of amino acids
Pardridge, W. M., & Oldendorf, W. H. (1975) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(75)90347-8 · Cited by 314
Peptide Drug Delivery to the Brain
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-783_2 · Cited by 308
Protein–protein interactions: PDZ domain networks
Fanning, A. S., & Anderson, J. M. (1996) · Current Biology · doi:10.1016/s0960-9822(96)00737-3 · Cited by 298
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino Acids
Pardridge, W. M. (1998) · Neurochemical Research · doi:10.1023/a:1022482604276 · Cited by 281
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
SASONGKO, L., LINK, J., MUZI, M., MANKOFF, D., YANG, X., COLLIER, A., SHONER, S., & UNADKAT, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.022 · Cited by 271
Kinetics of blood-brain barrier transport of hexoses
Pardridge, W. M., & Oldendorf, W. H. (1975) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(75)90279-5 · Cited by 244
de Lange, E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00014-3 · Cited by 226
In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain
Bendayan, R., Ronaldson, P. T., Gingras, D., & Bendayan, M. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6870.2006 · Cited by 220
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204
P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib
Chen, Y., Agarwal, S., Shaik, N. M., Chen, C., Yang, Z., & Elmquist, W. F. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154781 · Cited by 194
Zhang, R. D., Price, J. E., Fujimaki, T., Bucana, C. D., & Fidler, I. J. (1992) · PubMed Central · Cited by 186
Drug interactions at the blood-brain barrier: Fact or fantasy?☆
Eyal, S., Hsiao, P., & Unadkat, J. D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.017 · Cited by 186
Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology
(1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511570216 · Cited by 183
Carrier-mediated or specialized transport of drugs across the blood–brain barrier
Tsuji, A., & Tamai, I. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00084-2 · Cited by 174
Using positron emission tomography to facilitate CNS drug development
Lee, C.-M., & Farde, L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.004 · Cited by 168
Ronaldson, P. T., & Bendayan, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025973 · Cited by 145
Cytochrome P450–mediated drug metabolism in the brain
Miksys, S. L., & Tyndale, R. F. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120133 · Cited by 141
Pekmeability Changes in the Blood-Brain Barrier: Causes and Consequences
Pardridge, W. M., Connor, J. D., Crawford, I. L., & Oldendorf, W. H. (1975) · Critical Reviews in Toxicology · doi:10.3109/10408447509079857 · Cited by 137
Friedman, A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03227.x · Cited by 130
Ghosh, C., Gonzalez-Martinez, J. A., Hossain, M. K., Cucullo, L., Fazio, V. J., Janigro, D., & Marchi, N. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02428.x · Cited by 124
Bauer, B., Hartz, A. M. S., Lucking, J. R., Yang, X., Pollack, G. M., & Miller, D. S. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.16 · Cited by 123
Meyer, J., Rauh, J., & Galla, H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06411.x · Cited by 120
Heuristic modeling of drug delivery to malignant brain tumors
Levin, V. A., Patlak, C. S., & Landahl, H. D. (1980) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059646 · Cited by 117
Decreased junctional adhesion molecule-A expression during blood–brain barrier breakdown
Yeung, D., Manias, J. L., Stewart, D. J., & Nag, S. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0364-4 · Cited by 113
Ghersi‐Egea, J., Minn, A., & Siest, G. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90351-7 · Cited by 113
Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins
Tian, Q., Zhang, J., Tan, T. M. C., Chan, E., Duan, W., Chan, S. Y., Boelsterli, U. A., Ho, P. C., Yang, H., Bian, J., et al. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7595-z · Cited by 110
Deo, A. K., Theil, F., & Nicolas, J.-M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300570z · Cited by 107
Hawkins, B. T., Sykes, D. B., & Miller, D. S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-09.2010 · Cited by 107
Gynther, M., Ropponen, J., Laine, K., Leppänen, J., Haapakoski, P., Peura, L., Järvinen, T., & Rautio, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8015409 · Cited by 106
Chacko, A., Li, C., Pryma, D. A., Brem, S. S., Coukos, G., & Muzykantov, V. R. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.808184 · Cited by 106
Self-citationHalmos, T., Santarromana, M., Antonakis, K., & Scherman, D. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00796-0 · Cited by 93
Ravindran, J., Agrawal, M., Gupta, N., & Rao, P. V. (2010) · Toxicology · doi:10.1016/j.tox.2010.11.006 · Cited by 84
Wagner, K. R., Packard, B. A., Hall, C. L., Smulian, A. G., Linke, M. J., de Courten‐Myers, G. M., Packard, L. M., & Hall, N. C. (2002) · Developmental Neuroscience · doi:10.1159/000065703 · Cited by 82
Brain uptake of ketoprofen–lysine prodrug in rats
Gynther, M., Jalkanen, A. J., Lehtonen, M., Forsberg, M., Laine, K., Ropponen, J., Leppänen, J., Knuuti, J., & Rautio, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.019 · Cited by 79
Targeting the neurovascular unit for treatment of neurological disorders
VanGilder, R. L., Rosen, C. L., Barr, T. L., & Huber, J. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.12.004 · Cited by 76
Radiopharmaceuticals for single-photon emission computed tomography brain imaging
Kung, H. F., Kung, M., & Choi, S. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127296 · Cited by 66
Human Truncated Tau is Using a Different Mechanism from Amyloid-β to Damage the Blood-Brain Barrier
Kováč, A., Žilková, M., Deli, M. A., Žilka, N., & Novák, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1197 · Cited by 65
Prodrug based optimal drug delivery via membrane transporter/receptor
Yang, C., Tirucherai, G., & Mitra, A. K. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.2.159 · Cited by 64
Nicolazzo, J. A., & Katneni, K. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521580 · Cited by 57
O'Brien, F. E., O’Connor, R. M., Clarke, G. A., Dinan, T. G., Griffin, B. T., & Cryan, J. F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.120 · Cited by 55
Haarmann, A., Deiß, A., Prochaska, J. H., Foerch, C., Weksler, B. B., Romero, I. A., Couraud, P., Stoll, G., Rieckmann, P., & Buttmann, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013568 · Cited by 51
Novel models for assessing blood–brain barrier drug permeation
Geldenhuys, W. J., Allen, D. D., & Bloomquist, J. R. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677433 · Cited by 47
Nordborg, C., Sokrab, T., & Johansson, B. B. (1991) · Acta Neuropathologica · doi:10.1007/bf00293954 · Cited by 44
ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs
Vautier, S., & Fernandez, C. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903193079 · Cited by 44
Vogelgesang, S., Jedlitschky, G., Brenn, A., & Walker, L. C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440168 · Cited by 37
Fischer, W., Praetor, K., Metzner, L., Neubert, R. H. H., & Brandsch, M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.022 · Cited by 34
Tao, R., & Hjorth, S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11010.x · Cited by 32
Yee, R. E., Huang, S., Stout, D. B., Irwin, I., Shoghi, K. I., Togaski, D. M., DeLanney, L. E., Langston, J. W., Satyamurthy, N., Farahani, K., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741147.x · Cited by 27
Nakazawa, S., Yokoyama, C., Nishimura, N., Horisawa, T., Kawasaki, A., Mizuma, H., Doi, H., & Onoe, H. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2815-9 · Cited by 18
O'Brien, F. E., O’Connor, R. M., Clarke, G. A., Donovan, M. D., Dinan, T. G., Griffin, B. T., & Cryan, J. F. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.027 · Cited by 12
Cited by
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
The blood-brain barrier: Physiology and strategies for drug delivery
Pandit, R., Chen, L., & Götz, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.009 · Cited by 651
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Possible strategies to cross the blood–brain barrier
Bellettato, C. M., & Scarpa, M. (2018) · Italian Journal of Pediatrics · doi:10.1186/s13052-018-0563-0 · Cited by 258
Xiong, B., Wang, Y., Chen, Y., Xing, S., Liao, Q., Chen, Y., Li, Q., Li, W., & Sun, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00910 · Cited by 232
Metadata
- Authors
- Mikitsh, J. L., & Chacko, A.-M.
- Venue
- Perspectives in Medicinal Chemistry
- Publisher
- SAGE Publications
- Published
- 2014-01
- Volume
- 6
- Pages
- 11-24
- ISSN
- 1177-391X (ISSN-L)
- OpenAlex
- W1995336204
- Cited by
- 271
- References
- 92
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.